To assess the condition, accuracy and safety of mercury and anaeroid sphygmomanometers in use in general practice and to pilot a scheme for sphygmomanometer maintenance within the district. Design: Instruments were checked on site according to set protocols which related to established guidelines and standards and data were entered into a specially designed database. Mercury sphygmomanometers were removed to the laboratory for servicing. Practices received written feedback on the condition of each instrument checked, repairs undertaken and advice, where necessary, for further work required. Participant views on the scheme were sought. Materials and methods: A total of 472 instruments (75.4% mercury) located in 86 general practices (87.8% of practices participated) in a health district in the West Midlands. Instruments were checked against 28 (mercury) and 25 (anaeroid) quality standards and (for
Introduction
The accurate diagnosis and effective management of hypertension is undeniably essential in the prevention of cardiovascular diseases. Errors in blood pressure measurement therefore compromise the clinician's ability to achieve this. Measurement error may arise both from observer technique and defective equipment. Sphygmomanometers are relatively accurate provided they are well maintained with periodic calibration and adjustment. [1] [2] [3] The purpose of this study was to audit the condition of mercury and anaeroid sphygmomanometers in use in general practice in relation to accuracy and in addition, for mercury instruments) against British Hypertension Society guidelines. Results: 69.1% of mercury and 95.7% of anaeroid instruments checked, had no service records. Of the remainder, only 29 mercury (8.1%) and one anaeroid (0.9%) had a record of a check or service within the previous 12 months. None of the instruments met all of the relevant quality standards and 14 (3.9%) mercury and seven (6.1%) anaeroid instruments met less than half. A large proportion of mercury sphygmomanometers tested had defects likely to affect recommended measurement technique. Only two-thirds were accurate at all pressure levels tested. Only 38.8% of anaeroid instruments were accurate at all test pressure levels.
Conclusions:
The level of defects noted could have an impact on diagnosis and monitoring of hypertension. Journal of Human Hypertension (2001) 15, 681-684 mercury instruments, in relation to health and safety and affect on technique. The project also sought to pilot a local co-ordinated scheme for regular checking and service of sphygmomanometers. This collaborative project formed part of a wider multi-agency strategy for reduction in mortality from cardiovascular diseases in the district.
Setting and study design
The study was conducted within one health district in the West Midlands and involved 86 practices; 87.8% of the total. An initial letter was sent to all (98) local practices to introduce them to the project. All practices were sent a brief questionnaire requesting information on numbers and types of sphygmomanometers held by the practice. Nonresponders were contacted by telephone on at least one occasion. Protocols for equipment checks and servicing, record forms and the specially designed database were developed and piloted in five practices (broadly representing the local diversity in terms of location and size). All practices who agreed to participate in the project were visited by the project officer (and technician), who established the number, type and service history of instruments in use in the practice and checked their accuracy and condition against project protocols. Repairs on anaeroid instruments, where possible, were carried out on site, whereas mercury instruments were removed to the specially equipped laboratory for servicing (according to the existing relevant Health and Safety Executive regulations). Replacement sphygmomanometers were left in the practices for this period. All measurements and checks made were entered into the project database and practices received reports for their instrument after their return (within 24 h in 90% of cases). Follow-up questionnaires were sent to practices to ascertain their perception of the value and quality of the service offered.
Methods: project protocols
For the project, we developed a set of quality standards which were based on BS2743:1990 4 with the addition of others based on the British Hypertension Society guidelines 5 for blood pressure measurement technique which were designed to assess the effect of noted defects on likely measurement technique. The resulting set of project quality standards are given in Table 1 and relate to accuracy and health and safety. In relation to accuracy, the British Standards state that the mean reading from the sphygmomanometers must be within ±3 mm Hg of the calibration points selected: for the project these were 0, 50, 100, 150, 200, 250 mm Hg. All sphygmomanometers were checked for accuracy at these levels.
Results
In total 472 sphygmomanometers in regular use were located within the 86 participating practices. This number was greater than that initially reported by practices (314). Of these, 246 (69.1%) of mercury and 111 (95.7%) of anaeroid instruments had no service records. Of those which did, only 8.1% (mercury) and 0.9% (anaeroid) had a record of a service or check within the previous 12 months.
Mercury sphygmomanometers
None of the instruments tested met all of the relevant project standards or all of the relevant British Standards; 14 (39.3%) met less than half of the British Standards.
Accuracy: Figure 1 shows the proportion of instruments which met the accuracy standard at any combination of these pressure levels. For example, only 220 (61.8%) of instruments tested reached this level of accuracy at all six pressure levels and 12 sphygmomanometers met the accuracy standard at only three pressure levels and 13 were inaccurate at all pressure levels tested. For 20 instruments it was not possible to make reliable readings due to the condition of the glass tube. Only seven (2%) of instruments met all 15 of the standards considered important for accuracy of blood pressure measurement and 47 (13.2%) met seven or less.
Health and safety:
A total of 86% of mercury sphygmomanometers did not meet all five health and safety related standards.
Anaeroid sphygmomanometers
None of the instruments tested met all of the relevant project standards set or all of the relevant British Standards; seven (6.1%) met less than half of the British Standards.
Accuracy: Only 45 (38.8%) of sphygmomanometers tested were accurate at all seven pressure levels tested (0, 50, 100, 150, 200, 250, 300 mm Hg) (Figure 2 ). Only 29 (25%) of instruments met all 14 standards considered important for accuracy of blood pressure measurement and two (1.7%) met seven or less.
Pilot scheme
Of the 472 instruments tested on site, all but six mercury sphygmomanometers were taken to the laboratory for servicing and/or repair. In only six cases was it necessary to take aneroid instruments to the laboratory for this purpose. Over 90% of these instruments were returned to practices within 24 h. The pilot scheme included repair or replacement of Figure 2 Proportion of anaeroid sphygmomanometers meeting the accuracy standard at one or more of the seven pressure levels.
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washers, filters, gaskets, O-rings and mercury. Others repairs were separately agreed and paid for by practices. All practices received a written report on the outcome of the testing and any repairs carried out.
Participant survey
A total of 68% of participating practices returned the follow-up questionnaire which aimed to assess their level of satisfaction with the pilot scheme; 98% agreed with the aims of the scheme and 95% considered it 'worthwhile'; 61% considered that they had not been at all, and 35%, only slightly, inconvenienced by it. The majority were very (69%) or generally (24%) satisfied with the speed with which checks and subsequent servicing was carried out and 58% were very, and 35%, generally, satisfied with the feedback received. All responding participants declared an interest in a future, similar scheme.
Discussion
The measurement of blood pressure is probably the oldest and most frequently performed element of preventive care and the effective management of hypertension relies on the accurate measurement of blood pressure. Accuracy in blood pressure measurement relies upon the quality of the equipment and also on measurement technique. In this study, we focused on the condition of sphygmomanometers in regular use in general practice and found that there was much to be concerned about.
A large number of sphygmomanometers were located in use in general practice in the study health district. Of these, the checking and servicing appears to have been at best ad hoc and, in the absence of records, we could assume, probably not done at all. Where it had occurred (mainly by pharmaceutical company representatives), there was no evidence that it had been carried out according to recognised quality standards. The level of inaccuracy detected by this study (higher amongst anaeroid instruments) reflected the low extent to which the projects' (and British) quality standards were met. There exists therefore, a considerable risk of persistently inaccurate measurement of blood pressure and also, in the case of mercury sphygmomanometers, risks to the health and safety of observers and patients.
The likely impact of the noted deficiencies in the condition and operation of the sphygmomanometers on diagnostic and monitoring accuracy is difficult to predict and was not the objective of this project. A significant number of instruments were likely to be persistently over, or under reading. If this was compounded by poor measurement technique, the scenario of significant error in blood pressure measurement for large numbers of patients, with resulting inappropriate prescribing, becomes realistic.
Our findings are not alone in illuminating the poor state of the nations' sphygmomanometers. Two studies published recently in this journal 5, 6 which investigated the condition of equipment used in three large teaching hospitals (in London and Birmingham) concluded that, due to problems similar to those found here, '. . . more than half would have rendered them inaccurate in measuring blood pressure'. 5 The scheme which aimed to remedy these serious problems, proved to be effective and was well received by participating practices. The pertinence of such a scheme has however, been questioned, given the possibility of the phasing out of mercury sphygmomanometers on health and safety and environmental grounds. The European Council has been undertaking a 'risk assessment' exercise and the anticipated outcome from this is the limitation of mercury sphygmomanometers sales and marketing in the short-term. It is therefore unlikely that mercury instruments will be totally withdrawn from practice in the near future. The need for continued checking and maintenance of these important pieces of equipment therefore persists. Debate over what should, eventually, replace mercury sphygmomanometers continues, fuelled by the manufacturers of electronic equipment. The recognised inaccuracy of anaeroid instruments does not recommend them as mercury substitutes. Clearly there needs to be a coherent plan of action (linked to the National Service Framework for Coronary Heart Disease 7 ) to ensure that the equipment being used routinely and frequently to measure and monitor such an important aspect of patient care, is up to the job.
